Definitive Healthcare Share Price (NASDAQ: DH)

$4.04

▲

0.03

(0.75%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Definitive Healthcare Stock chart to analyse performance

Definitive Healthcare stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$3.99
Today's High:$4.04
$4.04
1.24%
Downside
Day's Volatility :1.24%
Upside
0.0%
52 Weeks Low:$2.15
52 Weeks High:$5.68
$4.04
46.78%
Downside
52 Weeks Volatility :62.15%
Upside
28.87%

Definitive Healthcare Stock Returns

Period	Definitive Healthcare Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	23.24%	3.6%	0.0%
6 Months	42.4%	-7.7%	0.0%
1 Year	-12.77%	-12.6%	0.0%
3 Years	-79.1%	9.5%	-4.7%

Definitive Healthcare Corp Key Stats

Check Definitive Healthcare key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$4.01
Open	$4.01
Today's High	$4.04
Today's Low	$3.99
Market Capitalization	$417.4M
Today's Volume	$140.1K
52 Week High	$5.68
52 Week Low	$2.15
Revenue TTM	$244.9M
EBITDA	$45.0M
Earnings Per Share (EPS)	$-2.69
Profit Margin	-124.43%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-67.34%

Stock Returns calculator for Definitive Healthcare Stock including INR - Dollar returns

The Definitive Healthcare stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Definitive Healthcare investment value today

Current value as on today

₹92,730

Returns

₹7,270

(-7.27%)

Returns from Definitive Healthcare Stock

₹12,554 (-12.55%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Definitive Healthcare Stock

138%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Definitive Healthcare Stock from India on INDmoney has increased by 138% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Definitive Healthcare Corp

Name
Holdings %
Name
Holdings %
Advent International LP
59.66%
Goldman Sachs Group Inc
8.35%
BlackRock Inc
3.90%
Vanguard Group Inc
2.79%
Palisade Capital Management LLc
2.16%
Dimensional Fund Advisors, Inc.
1.95%

Analyst Recommendation on Definitive Healthcare Stock

Rating

Trend

Buy

57%Buy

42%Hold

0%Sell

Based on 21 Wall street analysts offering stock ratings for Definitive Healthcare(by analysts ranked 0 to 5 stars)

Definitive Healthcare Share Price Target

What analysts predicted

Upside of 12.31%

Target:

$4.54

Current:

$4.04

Definitive Healthcare share price target is $4.54, a slight Upside of 12.31% compared to current price of $4.04 as per analysts' prediction.

Definitive Healthcare Stock Insights

Price Movement
In the last 3 years, DH stock has moved down by -79.8%
Increasing Revenue
Revenue is up for the last 2 quarters, 59.19M → 60.75M (in $), with an average increase of 2.6% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -107.22M → -7.55M (in $), with an average increase of 1320.1% per quarter
DH vs DOCS (1 yr)
In the last 1 year, Doximity, Inc. has given 84.7% return, outperforming this stock by 98.8%
DH vs DOCS (3 yr)
In the last 3 years, Doximity, Inc. has given 108.5% return, outperforming this stock by 188.3%
Price to Sales
ForDH every $1 of sales, investors are willing to pay $1.9, whereas for Doximity, Inc., the investors are paying $21.6 for every $1 of sales.

Definitive Healthcare Corp Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$85.5M	-
Net Income	$-36.4M	-
Net Profit Margin	-42.57%	-

	FY20	Y/Y Change
Revenue	$118.3M	↑ 38.38%
Net Income	$-51.2M	↑ 40.55%
Net Profit Margin	-43.24%	↓ 0.67%

	FY21	Y/Y Change
Revenue	$166.2M	↑ 40.43%
Net Income	$-51.9M	↑ 1.47%
Net Profit Margin	-31.24%	↑ 12.0%

	FY22	Y/Y Change
Revenue	$222.7M	↑ 34.0%
Net Income	$-7.2M	↓ 86.09%
Net Profit Margin	-3.24%	↑ 28.0%

	FY23	Y/Y Change
Revenue	$251.4M	↑ 12.92%
Net Income	$-202.4M	↑ 2702.38%
Net Profit Margin	-80.5%	↓ 77.26%

	FY24	Y/Y Change
Revenue	$252.2M	↑ 0.31%
Net Income	$-413.1M	↑ 104.12%
Net Profit Margin	-163.81%	↓ 83.31%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$63.5M	↓ 3.72%
Net Income	$-9.5M	↓ 6.99%
Net Profit Margin	-14.99%	↑ 0.53%

	Q2 FY24	Q/Q Change
Revenue	$63.7M	↑ 0.4%
Net Income	$-213.6M	↑ 2144.54%
Net Profit Margin	-335.18%	↓ 320.19%

	Q3 FY24	Q/Q Change
Revenue	$62.7M	↓ 1.63%
Net Income	$-130.9M	↓ 38.73%
Net Profit Margin	-208.78%	↑ 126.4%

	Q4 FY24	Q/Q Change
Revenue	$62.3M	↓ 0.65%
Net Income	$-59.1M	↓ 54.87%
Net Profit Margin	-94.84%	↑ 113.94%

	Q1 FY25	Q/Q Change
Revenue	$59.2M	↓ 4.97%
Net Income	$-107.2M	↑ 81.51%
Net Profit Margin	-181.16%	↓ 86.32%

	Q2 FY25	Q/Q Change
Revenue	$60.8M	↑ 2.63%
Net Income	$-7.6M	↓ 92.96%
Net Profit Margin	-12.43%	↑ 168.73%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$42.5M	-

	FY20	Y/Y Change
Profit	$87.8M	↑ 106.86%

	FY21	Y/Y Change
Profit	$125.5M	↑ 42.82%

	FY22	Y/Y Change
Profit	$180.0M	↑ 43.49%

	FY23	Y/Y Change
Profit	$164.9M	↓ 8.39%

	FY24	Y/Y Change
Profit	$197.5M	↑ 19.73%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$41.1M	↓ 5.57%

	Q2 FY24	Q/Q Change
Profit	$41.0M	↓ 0.04%

	Q3 FY24	Q/Q Change
Profit	$49.0M	↑ 19.46%

	Q4 FY24	Q/Q Change
Profit	$47.6M	↓ 2.91%

	Q1 FY25	Q/Q Change
Profit	$43.8M	↓ 8.07%

	Q2 FY25	Q/Q Change
Profit	$46.6M	↑ 6.52%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$21.6M	-
Investing Cash Flow	$-1.1B	-
Financing Cash Flow	$1.1B	-

	FY20	Y/Y Change
Operating Cash Flow	$23.2M	↑ 7.52%
Investing Cash Flow	$-23.9M	↓ 97.91%
Financing Cash Flow	$16.7M	↓ 98.52%

	FY21	Y/Y Change
Operating Cash Flow	$25.2M	↑ 8.59%
Investing Cash Flow	$-46.7M	↑ 95.84%
Financing Cash Flow	$384.4M	↑ 2207.85%

	FY22	Y/Y Change
Operating Cash Flow	$35.6M	↑ 41.12%
Investing Cash Flow	$-248.9M	↑ 432.63%
Financing Cash Flow	$-26.7M	↓ 106.95%

	FY23	Y/Y Change
Operating Cash Flow	$41.2M	↑ 15.77%
Investing Cash Flow	$-31.8M	↓ 87.23%
Financing Cash Flow	$-25.6M	↓ 4.17%

	FY24	Y/Y Change
Operating Cash Flow	$58.2M	↑ 41.29%
Investing Cash Flow	$-26.4M	↓ 16.91%
Financing Cash Flow	$-56.7M	↑ 121.81%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$16.6M	↑ 252.28%
Investing Cash Flow	$-24.0M	↓ 144.17%
Financing Cash Flow	$-17.2M	↑ 183.64%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$14.0M	↓ 15.37%
Investing Cash Flow	$14.9M	↓ 162.14%
Financing Cash Flow	$-14.1M	↓ 17.87%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$19.4M	↑ 38.4%
Investing Cash Flow	$9.0M	↓ 40.0%
Financing Cash Flow	$-12.1M	↓ 14.57%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$8.1M	↓ 58.14%
Investing Cash Flow	$-26.3M	↓ 393.16%
Financing Cash Flow	$-13.4M	↑ 10.8%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$26.1M	↑ 220.42%
Investing Cash Flow	$83.5M	↓ 418.02%
Financing Cash Flow	$-109.7M	↑ 720.66%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$9.3M	↓ 64.31%
Investing Cash Flow	$-10.2M	↓ 112.16%
Financing Cash Flow	$-24.7M	↓ 77.49%

Definitive Healthcare Technicals Summary

Sell

Neutral

Buy

Definitive Healthcare is currently in a neutral trading position according to technical analysis indicators.

Definitive Healthcare Corp Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Definitive Healthcare Corp	7.75%	42.4%	-12.77%	-79.1%	-90.69%
Tempus Ai	38.06%	48.79%	45.48%	88.27%	88.27%
Doximity, Inc.	18.52%	-0.73%	89.28%	107.86%	28.21%
Ge Healthcare Technologies Inc.	5.57%	-14.7%	-13.04%	21.9%	21.9%
Veeva Systems Inc.	-4.29%	22.99%	24.82%	57.09%	-8.43%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Definitive Healthcare Corp	NA	NA	NA	0.23	-0.67	-0.01	NA	2.9
Tempus Ai	34.26	34.26	NA	-0.73	-0.98	-0.12	NA	1.78
Doximity, Inc.	57.96	57.96	2.42	1.31	0.24	0.13	NA	5.47
Ge Healthcare Technologies Inc.	15.11	15.11	3.44	4.51	0.26	0.06	0.0	21.27
Veeva Systems Inc.	55.28	55.28	1.4	6.45	0.14	0.07	NA	40.6

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Definitive Healthcare Corp	Buy	$417.4M	-90.69%	NA	-124.43%
Tempus Ai	NA	$12.8B	88.27%	34.26	-20.98%
Doximity, Inc.	Hold	$12.7B	28.21%	57.96	39.88%
Ge Healthcare Technologies Inc.	Buy	$33.9B	21.9%	15.11	11.22%
Veeva Systems Inc.	Buy	$44.0B	-8.43%	55.28	27.29%

About Definitive Healthcare Corp

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

Organization	Definitive Healthcare
Employees	782
CEO	Mr. Kevin D. Coop
Industry	Technology

Key Management of Definitive Healthcare Corp

Name	Title
Mr. Jason Ronald Krantz	Founder & Executive Chairman
Mr. Kevin D. Coop	CEO & Director
Ms. Casey Heller	Chief Financial Officer
Mr. Jonathan Paris J.D.	Chief Legal Officer & Secretary
Ms. Marissa Peoples Odell	SVP & Head of Sales
Ms. Jeannine Lombardi	Chief Human Resources Officer
Mr. Benjamin Graboske	EVP, Technology, Engineering & Chief Data Officer
Ms. Rebecca Marani	Senior VP & General Manager
Ms. Kate Hastings	Chief Customer Officer
Ms. Sally Slarke	Senior Vice President of Commercial Center of Excellence

Important FAQs about investing in DH Stock from India :

What is Definitive Healthcare share price today?

Definitive Healthcare share price today is $4.04 as on August 30, 2025 at 1:29 am IST at the close of the market. Definitive Healthcare share today touched a day high of $4.04 and a low of $3.99.

What is the 52 week high and 52 week low for Definitive Healthcare share?

Definitive Healthcare share touched a 52 week high of $5.68 and a 52 week low of $2.15. Definitive Healthcare stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $4.04, lower by 28.87% versus the 52 week high.

How to invest in Definitive Healthcare Stock (DH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Definitive Healthcare on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Definitive Healthcare Shares that will get you 0.3713 shares as per Definitive Healthcare share price of $4.04 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Definitive Healthcare Stock (DH) from India?

Indian investors can start investing in Definitive Healthcare (DH) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Definitive Healthcare stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Definitive Healthcare share’s latest price of $4.04 as on August 30, 2025 at 1:29 am IST, you will get 2.4752 shares of Definitive Healthcare. Learn more about fractional shares .

What are the returns that Definitive Healthcare has given to Indian investors in the last 5 years?

Definitive Healthcare stock has given -90.69% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?